BostonGene, a leader in AI-powered solutions for drug discovery and development, has won Platinum in the AI Research Innovation category at the 2025 Pinnacle Awards. This recognition underscores ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium has published new consensus ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

According to ESC, these recommendations respond directly to a request from the European Commission to provide expert advice ...

Scientists have designed a new cognitive test that diagnoses patients more accurately with Alzheimer's. The digital test ...

TPD technologies, particularly PROTACs and MGDs, represent a paradigm shift in drug development by completely eliminating ...

Design We conducted a prospective, non-randomised cohort study on a cohort of abdominal or pelvic cancer patients who developed ... Results WMT significantly alleviated multiple clinical symptoms in ...

Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...